Aromatic L-amino acid decarboxylase deficiency: Clinical features, diagnosis, and treatment of a second family

Journal of Child Neurology

Volumn 12, Issue 6, 1997, Pages 349-354

  Maller, Alfreda ^a   Hyland, Keith ^b   Milstien, Sheldon ^c   Biaggioni, Italo ^d   Butler, Ian J ^a,e  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; AROMATIC LEVO AMINO ACID DECARBOXYLASE; BROMOCRIPTINE; HOMOVANILLIC ACID; PYRIDOXINE; TRANYLCYPROMINE;

ARTICLE; CASE REPORT; CATECHOLAMINE SYNTHESIS; CHILD; CLINICAL FEATURE; DRUG EFFICACY; ENZYME DEFICIENCY; HUMAN; MALE; MONOAMINE METABOLISM; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0030961201     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389701200602     Document Type: Article

References (41)

1. Kaufman S: A new cofactor required for the enzymatic conversion of phenylalanine to tyrosine. J Biol Chem 1958;230:931-939.
2. Kaufman S: The structure of the phenylalanine-hydroxylation cofactor. Proc Natl Acad Sci U S A 1963;50:1085-1093.
3. Brenneman AR, Kaufman S: The role of tetrahydropteridines in the enzymatic conversion of tyrosine to 3,4-dihydroxyphenylalanine. Biochem Biophys Res Commun 1964;17:177-183.
4. Nagatsu T, Levitt M, Udenfriend S: Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J Biol Chem 1964;239: 2910-2917.
5. Friedman PA, Kappelman H, Kaufman S: Partial purification and characterization of tryptophan hydroxylase from rabbit hind-brain. J Biol Chem 1972;247:4165-4173.
6. Kaufman S, Holtzman NA, Milstien S, et al: Phenylketonuria due to a deficiency of dihydropteridine reductase. N Engl J Med 1975; 293:785-790.
7. Duch DS, Smith GK: Biosynthesis and function of tetrahydrobiopterin. J Nutr Biochem 1991;2:411-423.
8. Hyland K: Abnormalities of biogenic amine metabolism. J Inherited Metab Dis 1993;16:676-690.
9. Niederwieser A, Blau N, Wang M, et al: GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia. Eur J Pediatr 1984;141:208-214.
10. Takikawa S-I, Curtius H-C, Redweick U, et al: Biosynthesis of tetrahydrobiopterin. Purification and characterization of 6-pyruvoyltetrahydropterin synthase from human liver. Eur J Biochem 1986;161:295-302.
11. Butler IJ, Koslow SH, Krumholz A, et al: A disorder of biogenic amines in dihydropteridine reductase deficiency. Ann Neurol 1978;3:224-230.
12. Kaufman S: Unsolved problems in diagnosis and therapy of hyperphenylalaninemia caused by defects in tetrahydrobiopterin metabolism. J Pediatr 1986;109:572-578.
13. Niederwieser A, Leimbacher W, Curtius HC, et al: Atypical phenylketonuria with "dihydrobiopterin synthetase" deficiency: Absence of phosphate-eliminating enzyme activity demonstrated in liver. Eur J Pediatr 1985;144:13-16.
14. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2012.
15. Brand MP, Heales SJ, Land JM, Clark JB: Tetrahydrobiopterin deficiency and brain nitric oxide synthase in the hph1 mouse. J Inherited Metab Dis 1995;18:33-39.
16. Tietz A, Lindberg M, Kennedy EP: A new pteridine requiring system for the oxidation of glycerol ethers. J Biol Chem 1964;239: 4081-4090.
17. Ziegler I, Schwuler U: Modulation of interleukin 2 high affinity binding by lymphocyte-derived tetrahydrobiopterin: Pterins as potential participants in the control of interleukin 2 receptor assembly. J Cell Biochem 1989;41:103-112.
18. Shen R, Zhang Y: Reduced pterins as scavengers for reactive oxygen species. Adv Exp Med Biol 1993;338:351-354.
19. Hyland K, Clayton PT: Aromatic amino acid decarboxylase deficiency in twins. J Inherited Metab Dis 1990;13:301-304.
20. Hyland K, Surtees RAH, Rodeck C, Clayton PT: Aromatic L-amino acid decarboxylase deficiency: Clinical features, diagnosis, and treatment of a new inborn error of neurotransmitter amine synthesis. Neurology 1992;42:1980-1988.
21. Craig SP, La Van Thai A, Weber M, Craig IW: Localization of the gene for human aromatic L-amino acid decarboxylase (DDC) to chromosome 7p13→p11 by in situ hybridization. Cytogenet Cell Genet 1992;61:114-116.
22. Christenson JG, Dairman W, Udenfriend S: On the identity of dopa decarboxylase and 5-hydroxytryptophan decarboxylase. Proc Natl Acad Sci USA 1972;69:343-347.
23. Lovenberg W, Weissbach H, Udenfriend S: Aromatic L-amino acid decarboxylase. J Biol Chem 1962;237:89-93.
24. Albert VR, Allen JM, Joh TH: A single gene codes for aromatic L-amino acid decarboxylase in both neuronal and non-neuronal tissues. J Biol Chem 1987;292:9404-9411.
25. Seifert WE, Foxx JL, Butler IJ: Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid. Ann Neurol 1980;8: 38-42.
26. Goldstein DS, Polinsky RJ, Garty M, et al: Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Ann Neurol 1989;26:558-563.
27. Hyland K: Estimation of tetrahydro, dihydro and fully oxidized pterins by high-performance liquid chromatography using sequential electrochemical and fluorometric detection. J Chromatogr 1985;343:35-41.
28. Howells DW, Smith I, Hyland K: Estimation of tetrahydrobiopterin and other pterins in cerebrospinal fluid using reversed-phase high-performance liquid chromatography with electrochemical and fluorescence detection. J Chromatogr 1986;381:285-294.
29. Hyland K, Howells DW: Review analysis and clinical significance of pterins. J Chromatogr 1988;429:95-121.
30. Hyland K, Clayton PT: Aromatic L-amino acid decarboxylase deficiency: Diagnostic methodology. Clin Chem 1992;38:2405-2410.
31. Joseph MH, Lafthouse R: The preservation of whole blood serotonin (5HT) and its determination using HPLC, in Bender DA, Joseph MH, Kochen W, Steinhart H (eds): Progress in Tryptophan Research 1987. Walter de Gruyter, Berlin, New York, 1987, pp 385-388.
32. Narisawa K, Arai N, Hayakawa H, Tada K: Diagnosis of dihydropteridine reductase deficiency by erythrocyte enzyme assay. Pediatrics 1981;68:591-592.
33. Arai N, Narisawa K, Hayakawa H, Tada K: Hyperphenylalaninemia due to dihydropteridine reductase deficiency: Diagnosis by enzyme assays on dried blood spots. Pediatrics 1982;70:426-430.
34. Fahn S: "On Off" phenomenon with levodopa therapy in parkinsonism. Neurology 1974;24:431-441.
35. Sharpless NS, McCann DS: Dopa and 3-O-methyldopa in cerebrospinal fluid of parkinsonism patients during treatment with oral L-dopa. Clin Chim Acta 1971;31:155-169.
36. Siow YL, Dakshinamurti K: Effect of pyridoxine deficiency on aromatic L-amino acid decarboxylase in adult rat brain. Exp Brain Res 1985;59:575-581.
37. Flower B: Recent advances in the mechanism of pyridoxine-responsive disorders. J Inherited Metab Dis 1985;1(Suppl 8):76-83.
38. Nutt TG, Fellman JH: Pharmacokinetics of levodopa. Clin Neuropharm 1984;7:35-49.
39. Gromova HA, Chubakov AR, Chumasov EI, Konovalov HV: Serotonin as a stimulator of hippocampal cell differentiation in tissue culture. Int J Dev Neurosc 1983;1:339-349.
40. Mattson MP: Neurotransmitters in the regulation of neuronal cytoarchitecture. Brain Res Rev 1988;13:179-212.
41. Nagatsu T: Genes for human catecholamine-synthesizing enzymes. Neurosci Res 1991;12:315-345.